All infants(n = 40) | Survivors(n = 28) | Labour ward deaths (n = 2) | Neonatal unit deaths(n = 10) | |
1 min Apgar, median (interquartile range) | 5 (2, 6) | 6 (4, 7) | 1 (1, 1) | 2 (1, 3) |
5 min Apgar, median (interquartile range) | 8 (6, 8) | 8 (7, 8) | 1 (0, 1) | 6 (4, 4) |
Cord pH, median (interquartile range) | 7.27 (7.23, 7.33) n = 10 | – | 7.22 (7.21, 7.29) n = 5 | |
Pneumothorax, n (%) | 15 (35) | 7 (25) | 0 | 8 (80) |
Intubated and ventilated, n (%) | 31 (78) | 19 (68) | 2 (100) | 10 (100) |
Nasal CPAP and never intubated, n (%) | 5 (13) | 5 (7) | – | 0 (0) |
Surfactant administered, n (% of those ventilated) | 25 (81) | 17 (89) | – | 8 (80) |
Chronic lung disease, n (%) | 14 (35) | 12 (43) | – | 2 (100)* |
Total duration (h) CPAP, median (interquartile range) | 28 (0, 447) | 112 (10, 522) | – | 0 (0, 0) |
HFOV | ||||
Number of infants, n (% ventilated infants) | 17 (55) | 8 (29) | – | 9 (90) |
Total duration (h), mean (SD) | 27 (0, 89) | 378 (10, 71) | – | 9 (2, 24) |
Postnatal steroids, n (%) | 3 (8) | 1 (4) | – | 2 (20) |
Retinopathy of prematurity stage 3 | 1 | 1 | – | 0 |
*Only two infants survived beyond 36 weeks’ corrected age.
CPAP, continuous positive airway pressure; HFOV, high-frequency oscillatory ventilation.